Corundum Neuroscience is a venture builder and fund advancing transformative neuroscience solutions from lab-to-life. The CNS team combines deep domain expertise with a track-record of venture-building success to accelerate neuroscience solutions across the entire innovation lifecycle. Taking a long-term investment approach, Corundum Neuroscience helps researchers, entrepreneurs and startups develop life-changing solutions that target specific disease areas and outcomes to enhance people's health, longevity and happiness. Corundum Neuroscience operates under parent company Corundum Innovation, a Japanese-based investment firm providing comprehensive support through research funding, venture investment services and new business consulting.